Correlation Between Aadi Bioscience and NeuroSense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Aadi Bioscience and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aadi Bioscience and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aadi Bioscience and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Aadi Bioscience and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aadi Bioscience with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aadi Bioscience and NeuroSense Therapeutics.

Diversification Opportunities for Aadi Bioscience and NeuroSense Therapeutics

0.73

Correlation Coefficient

Aadi Bioscience  NeuroSense Therapeutics

Poor diversification

The 3 months correlation between Aadi and NeuroSense is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Aadi Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aadi Bioscience are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Aadi Bioscience i.e., Aadi Bioscience and NeuroSense Therapeutics go up and down completely randomly.

Pair Corralation between Aadi Bioscience and NeuroSense Therapeutics

Given the investment horizon of 90 days Aadi Bioscience is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aadi Bioscience is 17.9 times less risky than NeuroSense Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  24.00  in NeuroSense Therapeutics Ltd on October 7, 2024 and sell it today you would earn a total of  12.00  from holding NeuroSense Therapeutics Ltd or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	73.79%
Values	Daily Returns

Aadi Bioscience  vs.  NeuroSense Therapeutics Ltd

Aadi Bioscience

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point.

NeuroSense Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aadi Bioscience and NeuroSense Therapeutics

The main advantage of trading using opposite Aadi Bioscience and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aadi Bioscience position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.

The idea behind Aadi Bioscience and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.